SMITH STEPHEN KEVIN
No ORCID on file
· 24 papers in corpus
· active 1995-2000
Frequent coauthors
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
2000
PCT No. PCT/GB95/01212 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/32708 PCT Pub. Date Dec. 7, 1995Disclosed are: a composition for use in the treatment of endometriosis, comprising an age…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1997
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…
1995
Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatm…